Final Director's Interest Notice
June 28, 2019
Imagion Biosystems has released Appendix 3Z Final Director’s Interest Notice. Read the Final Director’s Interest Notice.
Category: Investor updates
Director Resignation — Dr. John Hazle
June 27, 2019
Imagion Biosystems announces change to Board of Directors. Read the change to Board of Directors here.
Appendix 3Y x 5
June 27, 2019
Imagion Biosystems has released Appendix 3Y Change of Director’s Interest Notice. Read Appendix 3Y.
Appendix 3B
June 24, 2019
“Appendix 3B New issue announcement, application for quotation of additional securities and agreement” has been released by Imagion Biosystems. Read Appendix 3B here.
Release of Securities Subject to Escrow
June 7, 2019
Imagion Biosystems has announced “Release of Securities Subject to Escrow”. Read the announcement here.
Results of Annual General Meeting
May 31, 2019
Imagion Biosystems has announced Results of its 2018 Annual General Meeting. View Results of Annual General Meeting.
Chairman's Address to Shareholders at Annual General Meeting
May 31, 2019
Imagion Biosystems has announced “Chairman’s Address to Shareholders at Annual General Meeting”. View the Chairman’s Address.
Imagion Biosystems Successfully Completes Toxicology Study
May 23, 2019
Imagion Biosystems has achieved a key milestone in its progress to first-in-human testing with the successful completion of a toxicology safety study of its lead
Non-Deal Roadshow Presentation
May 21, 2019
The investor presentation “MagSense® Technology: Early Detection of Cancer Through Targeted Imaging” has been announced and is available for download here. Download the non-deal roadshow
Imagion Biosystems Receives R&D Advanced Overseas Finding
May 13, 2019
Imagion Biosystems is pleased to announce that it has successfully applied for an Advance/Overseas Finding in relation to its research and development activities for a